跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Stigmasan - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Stigmasan
Approved
STANDARD
Stigmasan
Tablets (India) Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ba5fa9ff3a917d57
Company
Tablets (India) Limited
Type
Standard
Approval Details
Approval Id
ba5fa9ff3a917d57
Drug Approval Philippines Name
Stigmasan
Product Name
Stigmasan
Registration Number
DRP-6823-07
Brand Name
Stigmasan
Generic Name
Neostigmine (as Methylsulfate)
Dosage Form
Solution for Injection (IM/IV/SC)
Dosage Strength
500 mcg/mL
Manufacturer
Tablets (India) Limited
Importer
Medinova Pharmaceutical Inc.
Distributor
Bansan Pharma Distributor
Company Detail Path
/organization/tablets-india-limited
Issuance Date
24 December 2024
Expiry Date
01 September 2028
Pharmacologic Category
Cholinesterase Inhibitors
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ba5fa9ff3a917d57
Type
Standard
Back to Philippines FDA Approvals